TBX2 and non-small cell lung carcinoma: We interrogated complimentary datasets and cohorts that utilized different technologies (arrays and next-generation sequencing) and comprised different phases in the pathogenesis of NSCLC, namely premalignant lung lesions and cytologically-normal airway epithelia in the cancerization field adjacent to tumors — all pointing to suppressed expression of the TBX2 subfamily in NSCLC.